Literature DB >> 4605402

Trimethoprim-sulphamethoxazole treatment in staphylococcal endocarditis and gram-negative septicemia.

E Bengtsson, M Svanbom, G Tunevall.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4605402     DOI： 10.3109/inf.1974.6.issue-2.13

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN： 0036-5548


× No keyword cloud information.
  4 in total

Review 1.  Antibacterial drugs today. I.

Authors:  A P Ball; J A Gray; J M Murdoch
Journal:  Drugs       Date:  1975       Impact factor: 9.546

2.  In vitro and in vivo efficacy of the combination trimethoprim-sulfamethoxazole against clinical isolates of methicillin-resistant Staphylococcus aureus.

Authors:  L P Elwell; H R Wilson; V B Knick; B R Keith
Journal:  Antimicrob Agents Chemother       Date:  1986-06       Impact factor: 5.191

3.  Treatment of experimental endocarditis due to methicillin-susceptible or methicillin-resistant Staphylococcus aureus with trimethoprim-sulfamethoxazole and antibiotics that inhibit cell wall synthesis.

Authors:  M de Górgolas; P Avilés; C Verdejo; M L Fernández Guerrero
Journal:  Antimicrob Agents Chemother       Date:  1995-04       Impact factor: 5.191

Review 4.  A new strategy to fight antimicrobial resistance: the revival of old antibiotics.

Authors:  Nadim Cassir; Jean-Marc Rolain; Philippe Brouqui
Journal:  Front Microbiol       Date:  2014-10-20       Impact factor: 5.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.